NPPA issued a notification regarding the

Oct 04, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific Compliance The National Pharmaceutical Pricing Authority (NPPA) on October 01, 2024, issued a notification regarding the fixation of the retail price of Gliclazide IP 60mg and metformin IP 500mg.

The following has been stated: -

•For each Gliclazide (in Modified release form) IP 60mg + Metformin (in extended release form) IP 500mg for M/s Unison Pharmaceuticals Pvt Ltd (Manufacturer) & (Marketer) the retail price is 09.74.

The detailed notification is given in the document attached below.

[Notification No. 19(4220)/2024/DP/NPPA/DIV.II]

View Document 1